Experienced in N-Acetylglutamate Synthase Deficiency

Dr. Agustin Martinez

Family Medicine
Agustin Martinez M D P A
250 E 49th St, 
Hialeah, FL 
44 Years of Experience
Experienced in N-Acetylglutamate Synthase Deficiency
Agustin Martinez M D P A
250 E 49th St, 
Hialeah, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Agustin Martinez is a primary care provider, practicing in Family Medicine in Hialeah, Florida. Dr. Martinez has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of N-Acetylglutamate Synthase Deficiency. His top areas of expertise are Rhabdomyolysis, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Gastrostomy, and Colonoscopy.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Family Medicine
Licenses
General Practice in FL
Hospital Affiliations
Keralty Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Agustin Martinez M D P A
250 E 49th St, Hialeah, FL 33013

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

2 Total Publications

Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.
Journal: British journal of clinical pharmacology
Published: March 26, 2025
Similar Doctors
Experienced in N-Acetylglutamate Synthase Deficiency
Dr. David Majure
Family Medicine
Experienced in N-Acetylglutamate Synthase Deficiency
Dr. David Majure
Family Medicine

Office

806 S Douglas Rd Ste 820, 
Coral Gables, FL 
 (7.3 miles away)
276-601-6197
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Majure is a primary care provider, practicing in Family Medicine in Coral Gables, Florida. Dr. Majure is rated as an Advanced provider by MediFind in the treatment of N-Acetylglutamate Synthase Deficiency. His top areas of expertise are Urinary Tract Infection in Children, Idiopathic Edema, Pseudomembranous Colitis, and Necrotizing Enterocolitis.

Experienced in N-Acetylglutamate Synthase Deficiency
Dr. Virgilio Del Pino
Family Medicine | General Practice
Experienced in N-Acetylglutamate Synthase Deficiency
Dr. Virgilio Del Pino
Family Medicine | General Practice
351 N Lejeune Rd, Suite 105, 
Miami, FL 
 (6.4 miles away)
786-235-1031
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Virgilio Del Pino is a primary care provider, practicing in Family Medicine and General Practice in Miami, Florida. Dr. Del Pino is rated as an Advanced provider by MediFind in the treatment of N-Acetylglutamate Synthase Deficiency. His top areas of expertise are End-Stage Renal Disease (ESRD), Peptic Ulcer, Necrosis, Gastrostomy, and Colonoscopy. Dr. Del Pino is currently accepting new patients.

Experienced in N-Acetylglutamate Synthase Deficiency
Dr. Oscar Mendez
Family Medicine
Experienced in N-Acetylglutamate Synthase Deficiency
Dr. Oscar Mendez
Family Medicine

Mendez Medical Center

5950 W Oakland Park Blvd Ste 300, 
Lauderhill, FL 
 (19.9 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Oscar Mendez is a primary care provider, practicing in Family Medicine in Lauderhill, Florida. Dr. Mendez is rated as a Distinguished provider by MediFind in the treatment of N-Acetylglutamate Synthase Deficiency. His top areas of expertise are Necrosis, Stroke, Sepsis, Gastrostomy, and Cardiac Ablation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Martinez's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 102 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile